This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from the 2019 American College of Rheumatology Foundation Guideline for the Management of Osteoarthritis...
All TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Stable. As always, this update includes the TreatGx standard of providing personalized dosing based on any applicable pharmacogenetics, kidney function, liver function, and drug interactions. This update was...
References 1 - https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134 2 - https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html 3 - https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73 4 - https://pubmed.ncbi.nlm.nih.gov/24798722/ 5 - https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling 6 - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642 7 - https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI 8 - https://www.einnews.com/pr_news/560810526/pharmacogenomics-market-is-estimated-to-reach-usd-11-97-billion-by-2028-emergen-research#:~:text=RESEARCH%20%2D%20EIN%20Presswire-,Pharmacogenomics%20Market%20is%20estimated%20to%20reach,billion%20by%202028%3A%20EMERGEN%20RESEARCH&text=Pharmacogenomics%20Market%20trends%20%E2%80%93%20Growing%20demand%20for%20personalized%20therapy...
All TreatGx users now have access to the updated treatment algorithm for Migraine Prophylaxis. This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. The algorithm now includes recommendations from...
All TreatGx users now have access to the updated treatment algorithm for Chronic Heart Failure. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. This update includes recommendations from the 2021 Update to...
